Innovations in HIV Testing (TI)
Human Immunodeficiency Virus
About this trial
This is an interventional other trial for Human Immunodeficiency Virus
Eligibility Criteria
FGD Inclusion Criteria:
- Females and males aged 18 - 24
- Able and willing to provide informed consent
- Residing in the selected villages
Observation Inclusion Criteria:
- Females and males aged 18 -24
- Able and willing to provide informed consent
- Residing in the selected villages
- Not known to be HIV positive (not reporting a previous positive test)
Sites / Locations
- Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Active Comparator
Focus Group Discussions
In Clinic Observation-Both
In Clinic Observation-Subject Choice
Focus group discussions (FGD) with young women (n=2 FGDs) and young men (n=2 FGDs) in the study area to determine the best way to offer self-testing to study participants.
10 young women and 10 young men were assigned and conducted BOTH of the HIV self-tests. Participants tried two different self-testing kits, one that is oral fluid based (saliva), Oraquick HIV Self Test, and one that is blood based via a finger prick, Atomo HIV Self Test. Oraquick HIV Self Test and Atomo HIV Self Test - Both
20 young women and 20 young men were assigned and conducted EITHER of the HIV self-tests. Investigators asked them to choose which test they would prefer to use, one that is oral fluid based (saliva), Oraquick HIV Self Test, or one that requires the use blood via a finger prick, Atomo HIV Self Test. Oraquick HIV Self Test - Choice; Atomo HIV Self Test - choice